Related Experiment Video
Updated: Jul 18, 2026
12:35
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
Measuring proliferation in breast cancer: practicalities and applications
Mark J Beresford1, George D Wilson, Andreas Makris
1Mount Vernon Cancer Centre, Northwood, Middlesex, UK. mjberesford@yahoo.co.uk
Breast Cancer Research : BCR
|December 14, 2006
Summary
Measuring tumor proliferation rates in breast cancer using methods like mitotic counts and cell cycle analysis is crucial. These proliferative indices can predict patient outcomes and treatment responses.
Area of Science:
- Oncology
- Pathology
Background:
- Accurate measurement of tumor cell proliferation is essential for understanding cancer biology and guiding treatment decisions.
- Various techniques exist for assessing tumor proliferation, each with specific strengths and limitations.
Purpose of the Study:
- To review existing and novel methods for measuring tumor proliferation rates in breast cancer.
- To discuss the clinical applications of proliferative indices as prognostic and predictive biomarkers.
Main Methods:
- Review of established methods: mitotic counts, S-phase fraction estimation, and immunohistochemistry of proliferation-associated antigens.
- Evaluation of evidence, advantages, and disadvantages of each method.
- Consideration of novel approaches in proliferation assessment.
Main Results:
- Different methods offer varying levels of accuracy, feasibility, and clinical utility for breast cancer.
- Proliferative indices derived from these methods show potential in stratifying patients.
- The review synthesizes current knowledge on proliferation measurement techniques.
Conclusions:
- Proliferative indices are valuable tools in breast cancer management.
- These indices can serve as prognostic indicators and predictors of response to systemic therapy.
- Further research into novel methods may enhance clinical decision-making.
